For families caring for someone with Alzheimer’s, a simple doctor’s visit can feel like a marathon. Getting out the door might mean managing resistance, confusion, and fear. The drive itself can heighten anxiety, and once at the clinic, bright lights and long waits often lead to agitation and exhaustion.
Now, a major new Alzheimer’s treatment breakthrough promises to lighten that load. The FDA has approved Leqembi® injections that can be given at home, marking a major leap forward in Alzheimer’s care.
What Leqembi Does
Leqembi (lecanemab-irmb) is an anti-amyloid therapy that targets the buildup of amyloid beta—proteins that form sticky clumps in the brain and contribute to memory loss and confusion.
When it first received FDA approval in 2023, patients needed to receive it by IV infusion every two weeks at a clinic or hospital. These regular appointments often disrupted daily life and created emotional strain for people already coping with memory loss.
Now, patients who complete the initial infusion phase may be eligible for once-weekly at-home injections using a quick, 15-second autoinjector. No travel, no waiting, and no added stress—just a more natural way to continue treatment.
The Difference It Makes
In clinical studies, Leqembi slowed cognitive decline by approximately 27% over an 18-month period. Nearly half of participants showed measurable reductions in amyloid plaque buildup. That progress represents not just medical advancement but meaningful time reclaimed.
The at-home version offers:
- Freedom from travel and waiting rooms
- Greater comfort and safety in familiar surroundings
- More time for what matters most—connection, rest, and normalcy
- A renewed sense of control for caregivers and loved ones
Why Outings Can Be So Difficult
Even short outings can cause stress for someone with dementia. They thrive on predictability, and breaking their routine often leads to confusion or frustration. Add sensory overload and fatigue, and a simple appointment can derail the entire day.
Alzheimer’s Care Moves Home
This shift to at-home Leqembi treatment mirrors a larger movement in health care: bringing medical support to where people feel safest—their homes. The benefits extend far beyond convenience.
At JFS Care, we see the power of home-based care daily. Our compassionate dementia caregivers help families maintain stability, dignity, and meaningful engagement. Whether it’s sharing a meal or reminiscing over old photos, these small moments are what keep life full of meaning.
The Road Ahead
Alzheimer’s continues to challenge families and researchers alike, but hope is growing. The approval of at-home Leqembi injections represents progress that acknowledges not just the disease, but the daily lives of those affected by it.
If your family is navigating the challenges of Alzheimer’s, you don’t have to do it alone. JFS Care provides expert in-home dementia care across Santa Monica, Brentwood, Sherman Oaks, and throughout the Los Angeles area, supporting both clients and caregivers with understanding and expertise.
Reach out to us any time at 213-383-2273 to learn how we can help make each day more manageable—and more meaningful.